Research focuses on new aerosol technology, bioaerosol particle characterization and size distribution, understanding and improving challenge dose delivery, deposition and retention in the lungs, and aerosol vaccination. We conduct and support research on animal model development, pathogenesis, host responses, prophylaxis, and therapy of disease/intoxication caused by exposure through the respiratory tract to aerosolized biological agents.